Profile
| Metric | Value |
|---|---|
| Full Name | Dynavax Technologies Corporation |
| Ticker | NASDAQ: DVAX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Specialty & Generic Drug Manufacturers |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | dynavax.com |
| Employees | 405 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $15.41 | |
| Price, 1D Change | 0.00% | |
| Market Cap | $2B | |
| - | ||
| PE Ratio | - | |
| Beta | 0.55 | |
| Revenue | $277M | |
| Revenue, 1Y Change | +19.36% | |
| EPS | $0.20 | |
| EPS, 1Y Change | +512.90% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:10 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | $0.20 | |
| EPS Estimate | -$0.50 | |
| EPS Est. Change | -344.14% | |
| Revenue | $277.25M | |
| Revenue Estimate | $338.75M | |
| Revenue Est. Change | +22.18% | |
| Current Price | $15.41 | |
| Price Target | - | $20.50 |
| Price Tgt. Change | - | +33.03% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.13 | -$0.05 | +61.85% | |
| $0.19 | $0.20 | +10.70% | |
| -$0.50 | N/A | -344.14% | |
| $0.33 | N/A | +61.13% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $229.42M | $232.28M | +1.25% | |
| $277.91M | $277.25M | -0.24% | |
| $338.75M | N/A | +22.18% | |
| $392.42M | N/A | +41.54% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | +22.11% | |
| Price, 3Y | +50.05% | |
| Market Cap, 1Y | +14.30% | |
| Market Cap, 3Y | +38.08% | |
| Revenue, 1Y | +19.36% | |
| Revenue, 3Y | -36.56% | |
| EPS, 1Y | +512.90% | |
| EPS, 3Y | -62.24% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $15.41 | |
| SMA 200 | $10.85 | |
| SMA 200 vs Price | -29.61% | |
| SMA 50 | $11.80 | |
| SMA 50 vs Price | -23.44% | |
| Beta | 0.55 | |
| ATR | $0.31 | |
| 14-Day RSI | 88.84 | |
| 10-Day Volatility | 191.61% | |
| 1-Year Volatility | 51.67% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| Dividends Paid | $0.00 | |
| Payout Ratio | 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $277.25M | |
| EPS | $0.20 | |
| Gross Profit | $227.80M | |
| Gross Margin | 82.17% | |
| Operating Profit | -$4.12M | |
| Operating Margin | -1.49% | |
| Net Income | $27.31M | |
| Net Margin | 9.85% | |
| EBITDA | $3.93M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.43 | |
| Current Ratio | 10.80 | |
| Quick Ratio | 9.91 | |
| - | ||
| F-Score | 6 | |
| Altman Z-Score | 2.71 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | - | |
| PS Ratio | 5.47 | |
| PB Ratio | 3.39 | |
| EV/EBITDA | 77.68 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $596.80M | |
| Cash & Equivalents | $713.83M | |
| Total Assets | $986.26M | |
| Current Assets | $848.94M | |
| Total Liabilities | $389.46M | |
| Current Liabilities | $78.63M | |
| Total Debt | $254.42M | |
| Short Term Debt | $4.18M | |
| Accounts Payable | $9.06M |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $249.94M | |
| Operating Expenses | $231.92M | |
| Cost Of Goods Sold | $49.45M | |
| SG&A | $0.00 | |
| D&A | $8.05M | |
| Interest Expense | $0.00 | |
| Income Tax | $3.55M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $66.51M | |
| CFI | -$18.04M | |
| CFF | -$102.02M | |
| Capex | $6.35M | |
| Free Cash Flow | $60.16M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| William Blair | → | |
| JMP Securities | → | |
| JMP Securities | → | |
| JMP Securities | → | |
| Goldman Sachs | → | |
| HC Wainwright & Co. | → | |
| Citizens Capital Markets | → | |
| Goldman Sachs | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with DVAX
Data Sources & References
- DVAX Official Website www.dynavax.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1029142/000162828025049536/0001628280-25-049536-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1029142/000102914225000049/0001029142-25-000049-index.htm
- DVAX Profile on Yahoo Finance finance.yahoo.com/quote/DVAX
- DVAX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/dvax
FAQ
What is the ticker symbol for Dynavax Technologies Corporation?
The ticker symbol for Dynavax Technologies Corporation is NASDAQ:DVAX
Does Dynavax Technologies Corporation pay dividends?
No, Dynavax Technologies Corporation does not pay dividends
What sector is Dynavax Technologies Corporation in?
Dynavax Technologies Corporation is in the Healthcare sector
What industry is Dynavax Technologies Corporation in?
Dynavax Technologies Corporation is in the Specialty & Generic Drug Manufacturers industry
What country is Dynavax Technologies Corporation based in?
Dynavax Technologies Corporation is headquartered in United States
When did Dynavax Technologies Corporation go public?
Dynavax Technologies Corporation initial public offering (IPO) was on February 19, 2004
Is Dynavax Technologies Corporation in the S&P 500?
No, Dynavax Technologies Corporation is not included in the S&P 500 index
Is Dynavax Technologies Corporation in the NASDAQ 100?
No, Dynavax Technologies Corporation is not included in the NASDAQ 100 index
Is Dynavax Technologies Corporation in the Dow Jones?
No, Dynavax Technologies Corporation is not included in the Dow Jones index
When was Dynavax Technologies Corporation last earnings report?
Dynavax Technologies Corporation's most recent earnings report was on November 5, 2025
When does Dynavax Technologies Corporation report earnings?
The next expected earnings date for Dynavax Technologies Corporation is February 19, 2026
